help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on May 8, 2003, doi:10.1165/rcmb.2002-0167OC
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-0167OCv1
30/1/51    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mascarenhas, M. M.
Right arrow Articles by Quinn, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mascarenhas, M. M.
Right arrow Articles by Quinn, D. A.
American Journal of Respiratory Cell and Molecular Biology. Vol. 30, pp. 51-60, 2004
© 2004 American Thoracic Society
DOI: 10.1165/rcmb.2002-0167OC

Low Molecular Weight Hyaluronan from Stretched Lung Enhances Interleukin-8 Expression

Marcella M. Mascarenhas, Regina M. Day, Cristiaan D. Ochoa, Won-Il Choi, Lunyin Yu, Bin Ouyang, Hari G. Garg, Charles A. Hales and Deborah A. Quinn

Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston; Division of Pulmonary and Critical Care, Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts; and Division of Critical Care Medicine, Medellín General Hospital and Pontifical Bolivarian University, Medellín, Colombia

Address correspondence to: Marcella M. Mascarenhas, Ph.D., Pulmonary and Critical Care Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch-148, Boston, MA 02114. E-mail: mmascarenhas{at}partners.org


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mechanical ventilation has been shown to cause ventilator-induced lung injury (VILI), probably by overdistending or stretching the lung. Hyaluronan (HA), a component of the extracellular matrix, in low molecular weight (LMW) forms has been shown to induce cytokine production. LMW HA is produced by hyaluronan synthase 3 (HAS 3). We found that HAS 3 mRNA expression was upregulated and that LMW HA accumulated in an animal model of VILI. We hypothesized that stretch-induced LMW HA production that causes cytokine release in VILI was dependent on HAS 3 mRNA expression. We explored this hypothesis with in vitro lung cell stretch. Cell stretch induced HAS 3 mRNA expression and LMW HA in fibroblasts. Nonspecific inhibitors of HAS 3 (cyclohexamide and dexamethasone), a nonspecific inhibitor of protein tyrosine kinases (genistein), and a janus kinase 2 inhibitor (AG490) blocked stretch-induced HAS 3 expression and synthesis of LMW HA. Stretch-induced LMW HA from fibroblasts caused a significant dose-dependent increase in interleukin-8 production both in static and stretched epithelial cells. These results indicated that de novo synthesis of LMW HA was induced in lung fibroblasts by stretch via tyrosine kinase signaling pathways, and may play a role in augmenting induction of proinflammatory cytokines in VILI.

Abbreviations: acute respiratory distress syndrome, ARDS • chondroitin sulfate, CS • extracellular matrix, ECM • extracellular signal–regulated kinase, ERK • hyaluronan, HA • hyaluronan synthase 3, HAS 3 • Hanks' buffered saline solution, HBSS • high molecular weight, HMW • interleukin, IL • Janus kinase, JAK • low molecular weight, LMW • lipopolysaccharide, LPS • macrophage inflammatory protein, MIP • polymerase chain reaction, PCR • proteoglycans, PGs • reverse transcription, RT • ventilator-induced lung injury, VILI


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Positive pressure mechanical ventilation is life-saving in patients with acute respiratory distress syndrome (ARDS), but it can lead to ventilator-induced lung injury (VILI). Because lung damage in ARDS is not homogeneous, some areas are less involved than others. These less involved areas are more compliant and thus can be overdistended by mechanical breaths of even moderate volume.

In rat models of VILI that employed whole lung stretch to mimic the regional alveolar overdistention seen in human patients with ARDS, large tidal volumes were shown to produce noncardiogenic pulmonary edema, accumulation of neutrophils, and elevated levels of chemoattractant cytokines such as macrophage inflammatory protein-2 (MIP-2) (1). Fibroproliferative changes were also observed in VILI models, and these may contribute further to changes in lung function (28). It has been demonstrated by some but not all investigators that in ex vivo experiments with rat and mouse lungs, positive pressure ventilation at very large tidal volumes of 40 ml/kg produced an outpouring of inflammatory cytokines and chemokines, including MIP-2, tumor necrosis factor-{alpha}, and interleukin (IL)-6. We previously showed that the stretch-induced release of MIP-2 led to the infiltration of leukocytes, which are part of the tissue response to injury in VILI (9). In cell stretch models, we have also shown that stretch directly induces IL-8 production (10). However, additional mechanisms contributing to increased cytokine production may also occur in VILI.

The mechanism of lung inflammation in VILI is not well understood. Changes in the extracellular matrix (ECM) may be involved. Pulmonary fibroblasts, which are located in the lung interstitial space of capillary wall throughout the lung parenchyma and within the large vessels and airways, are uniquely situated to sense changes in mechanical force. These interstitial fibroblasts undergo significant cyclic stretch during mechanical ventilation, which may play a key role in contributing to ECM-induced inflammatory changes in VILI. Hyaluronan (HA), which is composed of disaccharide repeats, with alternating glucuronic acid and N-acetyl glucosamine, is an important component of the ECM. In its native state, HA exists as a high molecular weight (HMW) form, and serves as a structural scaffolding in tissue. HA also accumulates (11) in low molecular weight (LMW) forms (200 kD) at sites of inflammation, where it is implicated in multiple proinflammatory activities: monocyte activation, leukocyte adhesion to endothelium, smooth muscle cell migration after wound healing, and induction of chemokines such as macrophage chemoattractant protein-1{alpha} (MCP-1{alpha}), MCP-1ß, RANTES, and IL-8 (1214). HA is synthesized by hyaluronan synthase (HAS) that is located in the cell membrane, and secreted into the interstitial space. Three isotypes of HAS have been described, but their functional roles in vivo have not been elucidated. However, in mammalian cell culture, HAS 1 and 2 produce HMW HA, whereas HAS 3 produces LMW forms of HA (15).

Cyclic stretch of cells in culture has been shown to activate a number of signal transduction pathways, including protein tyrosine kinases (PTK) (16), janus kinase (JAK) (17), and mitogen-activated protein kinases, extracellular signal–regulated kinase 1/2 (ERK1/2) (16). Other reports have implicated these pathways in remodeling of the ECM in response to cytokines and growth factors (18). These pathways have not previously been explored in stretch-induced remodeling of the ECM via HAS.

In the present study, we hypothesized that stretch-induced LMW HA production that causes cytokine release in VILI is dependent on increased HAS 3 mRNA expression. To investigate this hypothesis, intact rats were ventilated for 2 h with a modestly increased tidal volume (VT) of 20 cc/kg at 85 breaths/min, followed by measurements of both HA quantity and HAS 3 mRNA expression in the lung. The mechanisms of stretch-induced HA production were explored using an in vitro model of stretch using primary fetal and adult lung fibroblasts. We find that LMW forms of HA are produced in both in vivo and in vitro models of stretch, and in both cases, the LMW HA is accompanied by increased levels of HAS 3 mRNA. We also find that in vitro stretch of fetal and adult lung fibroblasts upregulates expression of activated JAK 2 (p-JAK 2). Furthermore, we find that stretch-induced accumulation of LMW HA and upregulation of HAS 3 mRNA in vitro can be inhibited by cyclohexamide or dexamethasone, nonspecific inhibitors of HAS 3 mRNA. We also show that stretch-induced HAS 3 mRNA and accumulation of HA can be inhibited by the nonspecific PTK inhibitor genistein, and by the JAK 2 inhibitor AG490. Finally, we show that LMW HA produced by cyclic stretch of fibroblasts induces IL-8 production in static cells, and augments stretch-induced cytokine production in vitro.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Experimental Animals and Ventilator Protocol
Sprague-Dawley virus-free rats weighing between 200 and 300 g were obtained from Charles River Laboratories (Wilmington, MA).

Under general anesthesia with intraperitoneal ketamine (50 mg/kg; Bedford Laboratories, Bedford, OH) and diazepam (5 mg/kg; Elkins-Sinn, Cherry Hill, NJ), the animals were orally intubated with a 2.42-mm OD (1.67 ID) polyethylene catheter. They were then attached to a small animal ventilator model 683 (Harvard Apparatus Inc, Holliston, MA) set to deliver 20 cc/kg or 7 cc/kg VT at a rate of 85 breaths/min for 2 h on room air. The animals remained intact and with closed chests (19). A VT of 20 cc/kg was used to mimic the overdistention of normal lung thought to occur in uninvolved lung during mechanical ventilation in human ARDS. The tidal volume delivered by the ventilator was checked by fluid displacement from an inverted calibration cylinder. Intubation tubing was increased in length at VT 20 cc/kg to provide adequate dead space to maintain PCO2 at 30–40 mm Hg. All animals were ventilated without positive end-expiratory pressure (PEEP). After 2 h of ventilation, the animals were killed, and their lungs removed en bloc, flash frozen in liquid nitrogen, and stored at –70°C. Control nonventilated animals were anesthetized as above, killed, and their lungs harvested as done for ventilated animals.

Immunohistochemistry
After ventilation, lung tissue was harvested and fixed in 10% phosphate-buffered formalin, embedded in paraffin, and cut in 10-µm sections. HA was localized using an avidin-biotin-peroxidase histochemical technique. Briefly, the sections were incubated with a biotinylated fragment of HA binding region (bHABP 1:1,000) of aggrecan. After washes, the bHABP was detected using horseradish peroxidase–conjugated streptavidin (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, CA). Colored reaction product was developed using diaminobenzadine (Sigma, St. Louis, MO). As control for specificity, sections from ventilated animals were incubated with 5 U/ml Streptomyces hyaluronidase (Sigma) at 37°C for 30 min followed by biotinylated bHABP and detection of bHABP using the method as above.

HA expression was quantified using microscopic image analysis. After staining slides for HA, the fields were chosen randomly from all sections and captured using a digital camera. Then intensity and area of HA in different groups was measured using IP imaging analysis lab software (Scanalytics, Inc., Fairfax, VA).

Maintenance of Cell Cultures and Stretching
Lung fibroblasts are a known source of HA in the lung. Studies were initially performed in human fetal fibroblasts, which are fast growing, and then key results were confirmed in normal human adult fibroblasts. IMR-90 human fetal fibroblasts (Coriell Labs, Camden, NJ), were maintained in RPMI 1640 medium (Gibco, Grand Island, NY) supplemented with 20% fetal bovine serum (Gibco), 1% penicillin/streptomycin, and 0.1% Fungisone. Normal human adult fibroblasts (NHLFs; Clonetics Inc., San Diego, CA) were maintained on FGF-2 Bullet Kit (Clonetics Inc.). Type II–like epithelial cells (A549 cells), a source of IL-8 production, were used to test the proinflammatory effects of HA. A549 cells were maintained in F-12K medium (Gibco) in 10% fetal bovine serum (Gibco), 1% penicillin/streptomycin, and 0.1% Fungisone. BEAS-2B bronchiolar epithelial cells (ATCC, Rockville, MD), a source of IL-8 production, were used to confirm the proinflammatory effects of HA. BEAS-2B bronchiolar epithelial cells were maintained in BEGM Bullet Kit (Clonetics Inc.).

Fibroblasts were seeded at 2 x 106 cells/dish onto sterile silicone membranes mounted on a polypropylene dish for use in mechanical strain device. On the day of stretch, plates were washed with Hanks' buffered salt solution (HBSS) and serum-free medium was added. The plates were placed on a mechanical deforming device. This stretching device was custom built and provided by Martha Gray, Ph.D. (Massachusetts Institute of Technology, Cambridge, MA) and has been previously been described in detail (20, 21 This device provides sinusoidal, spatial homogenous and isotropic biaxial strain to cultured cells. Cells were subjected to stretch at 60 cycles/min with 15% strain for 0.5, 1.0, 2.0, or 4.0 h. These parameters were selected to approximate the conditions used in the ventilated rats. More intensive stretch was not possible with this apparatus. Parallel dishes of control cells were seeded identically and maintained for the same intervals without mechanical deformation.

A549 cells were also stretched as described above, for measurement of IL-8 production. The cell density was 3 x 106 cells/plate. Cells were stretched for 4 h at 20 cycles/min followed by a 2-h static culture to allow time for protein production. We have used this stretch protocol in A549 cells extensively and have established it as a reproducible model of stretch-induced IL-8 production (10). LMW HA and HMW HA were added to the A549 cells with and without stretch.

Extraction of Proteoglycans
Lung tissue was pooled from 20–25 rats as a set and frozen at -70°C for later extraction of proteoglycans (PGs). PGs were extracted from three sets of VT 20 cc/kg, two sets of VT 7 cc/kg, and three sets of controls (nonventilated). Lung tissue was homogenized with 4 M guanidium HCl, 50 mM sodium acetate, 9 mM Na-EDTA, 1 mM p-chloromercuribenzoate, and 1 mM phenylmethyl sulfonyl fluoride pH 5.8, for 30 s, three times. The homogenate was stirred at 4°C for 48 h and centrifuged at 200,000 x g for 30 min, twice. The supernatants were pooled and exhaustively dialyzed against distilled water, using spectra/Por 3 (Fisher Scientific Inc., Pittsburgh, PA) molecular porous membrane tubing followed by dialysis against 6 M urea in 50 mM sodium acetate pH 5.8 (Buffer A). The extraction conditions of proteoglycans from all VT conditions were identical.

For DEAE anion exchange chromatography, the dialysate as applied directly to a 15 cm x 2 cm column packed with Whatman DE-52 anion exchange resin and equilibrated with Buffer A. Fractions were eluted in sequence with 250 ml Buffer A, followed by 250 ml of a linear gradient of 0–0.2 M NaCl in Buffer A. HA eluted first from the column, due to its lower charge compared with the remaining PGs, which were highly sulfated, carry a higher charge, and therefore bind more firmly to the column. Therefore, the remaining PGs elute at a higher salt concentration. To quantify the PG content in column fractions, uronic acid was determined by the method of Bitter and Muir (22). Pooled uronic acid–containing peaks were dialyzed and lyophilized at -70°C at 10 mm Hg to complete dryness. The column conditions used with all extracts were identical. Uronic acid measurements were repeated after lyophilization and redissolution.

For the measurement of PGs from the cultured cells, culture supernatants from stretched cells and control cells were dialyzed at 4°C. The PGs were then extracted using 4 M guanidinium HCl containing protease inhibitors as described above for PG extraction and quantification from rat lung tissue.

Identification of PGs by Cellulose Acetate Electrophoresis
Electrophoresis of PGs was performed on cellulose acetate strips (Helena Lab, Beaumont, TX) using the method of Campelletti and coworkers (23) to identify the specific PGs present in VILI. Lyophilized column fractions from lung tissue and glycosaminoglycan (GAG) extract from stretch cell culture supernatant of fibroblasts were separated by electrophoresis on cellulose acetate. GAG standards: HA, chondroitin sulfate (CS), heparan sulfate, dermatan sulfate, and heparin were included in each electrophoretic analysis. The identity of HA determined by this method was confirmed by treatment of an aliquot of this material with Streptomyces hyaluronidase (HAdase) (0.05 U/2-µg sample) at 60°C for 72 h, followed by enzyme inactivation at 100°C. HAdase enzyme has been shown to be specific for the breakdown of HA. The HAdase treated fraction was dialyzed against distilled water and freeze-dried, then reanalyzed by cellulose acetate electrophoresis, which showed that the band had disappeared.

The PG identified as CS on cellulose acetate plates was confirmed as CS by Condroitin ABCase (0.1 U/100 µg in Tris acetate buffer pH 8.0) for 30 min, followed by inactivation at 100°C. Condroitin ABCase enzyme have been shown to be specific for the breakdown of CS. The Condroitin ABCase treated fraction was dialyzed against distilled water, freeze-dried, and analyzed on cellulose acetate plates as done for the HAdase-treated sample.

Size Fractionation of Rat Lung HA on 0.5% Agarose Gel Electrophoresis
HA samples were analyzed for size by agarose gel electrophoresis, performed according to the method of Cowman and colleagues (24). Briefly, samples were loaded onto 0.5% agarose gels and electrophoresed using an FB-LSU-1 horizontal electrophoresis system (Fisher Scientific, Pittsburgh, PA). Gels were stained with 0.5% alcian blue in 1 N acetic acid. The gel was destained with 3% acetic acid for 3 d. The molecular weights of the HA samples obtained in VILI models were determined by relative mobility compared with standards of known molecular weight over the range 200–5,000 kD (Biomatrix Inc., Ridgefield, NJ). All samples were analyzed by the same method.

Size Fractionation and Purification of HA from Fibroblasts by Sepharose CL-4B
HA samples extracted from stretched fibroblast culture supernatants were separated and purified using Sepharose CL-4B size exclusion chromatography (150 cm x 2 cm) equilibrated in 0.05 M sodium acetate buffer pH 6.7. The column was calibrated in the following manner: void volume (Vo) was measured using Dextran blue 2000; total volume (Vt) was measured using uronic acid; HA sizes were determined by relative elution volume (Kaw) compared with three HA standards of known molecular weight (1,600 kD, 370 kD, and 178 kD) (Sigma Chemical Co. and Biomatrix Inc.). All samples were analyzed by the same method. By this method, all HA samples were size-fractionated and purified for further analysis. The LMW HA from stretched fibroblasts and HMW HA from nonstretched fibroblasts were then dialyzed and lyophilized before use in cell stimulation studies using A549 cells. We also confirmed the purity of HA in the column fraction of fetal fibroblasts by FT-IR spectroscopic analysis.

RT-PCR for HAS
Total cellular RNA from rat lung was isolated using totally RNA kit (Ambion Inc., Austin, TX). For fibroblasts, total cellular RNA was isolated in 4 M guanidine hydrochloride, and the RNA was purified by ultracentrifugation through a 5.7-M CsCl cushion or RNAqueous (Ambion Inc.).

RNA was reverse transcribed (RT) using Gene Amp polymerase chain reaction (PCR) core kit (Perkin Elmer) following the manufacturer's instructions. The 20 µl RT mixture contained 1 µg total RNA, 1 mM dNTP, 2.5 µM random hexamers, 5 mM Mg Cl2, and 2.5 U/µl reverse transcriptase (RTase). The RT was performed at 42°C for 45 min, after which enzyme was inactivated by a 5-min incubation at 99°C.

Murine HAS sequences, which are 90–99% homologous with rat, were used for this analysis. The primers had the following sequences: 5'-AGTATACCTCGCGCTCCAGA-3' up, 5'-AGCAGCAGTAGAGCCCAGAG-3' down; AACAGGGTGTTGAGTCTGGG-3' up, 5'-TAAACCACACGGACACTGGA-3' down; and 5'-CGGGTGAAGGAGAGACAGAG-3' up, 5'-GCAATGAGGAAGAATGGGAA-3' down. These resulted in reaction products of 481 bp for HAS 1, 502 bp for HAS 2, and 712 bp for HAS 3. PCR for GAPDH was performed as a control, using the following primers: 5'-AATGCATCCTGCACCACCAA-3' up and 5'-GTAGCCATATTCATTGTCATA-3' down, which gives a 516-bp product.

The human primers used for studies in cultured fibroblasts were: 5'-TCATGGTGGTGGATGGCAACCGC-3' and 3'-CTAAGCCACCTGATGTACGTCCA-5', which gave rise to a 283-bp reaction product with HAS 3 and 324-bp product with HAS 1. For HAS 2, primers used were 5'-ATTGTTGGCTACCAGTTTATCCAAACGG-3' and 3'-GGCCACTCTGTCTACTCAGTGTATTTCTTT-5', which gives 409 bp reaction product. PCR for tubulin-ß was performed as a control using: 5'-CTCCATCCTTCACCACCCACA-3' and 5'-CAGGGTCACATTTCACACCATCT-3', which gives a 365-bp product.

The 25-µl PCR reaction contained 0.14 µM each primer (Sigma Chemical Co.), 2.5 U/µl AmpliTaq DNA polymerase, 2 mM MgCl2, and 0.2 µM dNTP. The following cycling parameters were used: denaturation at 94°C for 2 min, followed by 35 cycles of 95°C for 1 min, annealing at 58°C for 2 min, and extension at 72°C for 2 min, with a terminal extension at 72°C for 7 min.

Inhibition of HA Synthase
Initial studies of inhibition of HA synthase in human fetal fibroblasts were performed with the known nonspecific inhibitors cyclohexamide (10 pM) and dexamethasone (10 nM). To explore the role of tyrosine kinases in stretch-induced HA mRNA expression and HA production, the nonspecific protein tyrosine kinase inhibitor genistein (10 µM), and AG490, a specific inhibitor of JAK2 (1 µM), were used. A specific inhibitor of MEK1/2, UO126 (at 20 µM), was used to investigate the role of ERK1/2 in stretch-induced HA mRNA expression and HA production . Cells were exposed to inhibitors for 4 h before stretch, in serum-free medium. Supernatants and cell extracts of nonstretched fibroblasts were harvested at the same time as stretched fibroblasts. Key findings of the stretch–response changes in the ECM and its signal transduction pathway in fetal fibroblasts were confirmed in the adult fibroblasts.

Immunoblot Analysis for JAK-2
Cell lysates were normalized for protein concentration (BioRad, Inc., Hercules, CA) and resolved on a 10% bis-acrylamide gel, then electrotransferred to Immunobilon-P membranes (Millipore Corp., Bedford, MA). Blots were blocked overnight at 4°C with 5% powdered milk dissolved in TBST (20 nM Tris, pH 7.6, 137 mM NaCl, and 0.1% Tween-20), incubated with p-Jak2/ total Jak2 (to confirm equal loading)(1:200; Santa Cruz Biotechnology, Santa Cruz, CA) for 2 h at room temperature, washed with TBST, blocked with 5% milk in TBST, then incubated with horseradish peroxidase–conjugated anti-rabbit IgG (1:3000) for 1 h at room temperature. Blots were developed by enhanced chemiluminescence (NEN Life Science Products, Boston, MA).

Stimulation of A549 Cells with HA
A549 and BEAS-2B bronchiolar epithelial cells were used as a potential source of IL-8, to test the pro-inflammatory properties of HA. These experiments were conducted with static, nonstretched cells and also cells exposed to cyclic stretch. To limit the number of rats used in the study, pilot studies were performed with HA that was commercially purchased instead of isolating from rat lungs. LMW HAs were purchased from Sigma Chemical Co. and ICN Biochemicals. HMW HA was purchased from Sigma Chemical Co. Key findings were confirmed using LMW and HMW HA purified on Sepharose CL 4B from stretched fetal fibroblasts.

On the day of stimulation, cultures of A549/ BEAS-2B bronchiolar epithelial cells were washed with HBSS and then treated with LMW HA or HMW HA for 6 h at 37°C, at concentrations of 10, 50, 100, 150, and 200 µg/ml media. Contamination of HA samples by lipopolysaccharide (LPS), which could result in artifactual production of IL-8, was checked in two ways. First, 10 µg/ml polymyxin B was included in all cultures. Second, LPS was quantified in cultures by a Limulus endotoxin assay (Sigma Chemical Co.). Less than 0.03 endotoxin units (EU)/ml (a negative) was detected in any sample: HMW HA, LMW HA, or media with/without Polymyxin B.

For HA stimulation of cells in stretch culture, on the day of stimulation, cultures were washed with HBSS and then treated for 6 h with LMW HA and HMW HA at a dose of 100 µg/ml media and 10 µg/ml polymixin B to inhibit the production of IL-8 by contaminating LPS in sample. LPS was monitored by the Limulus endotoxin assay (Sigma Chemical Co.). Less than 0.03 EU/ml (negative test) was detected in HMW HA, LMW HA, and media with/without Polymixin B.

In static cells, four controls were also run along with the treated cultures: (i) control with no added HA; (ii) HAdase-treated HA (Streptomyces hyaluronidase [0.05 U/2-µg sample] at 60°C for 72 h followed by inactivation at 65°C for 10 min, which destroys all the HA in the sample); (iii) heat-treated HA (100°C for 10 min, which denatures any possible protein contamination in the fraction); and (iv) DNase treated HA (10 U DNase I for 1 h at 37°C followed by inactivation at 65°C for 10 min, which removes trace amounts of DNA contamination in the sample).

Analysis of IL-8 Protein
Cell supernatants were removed and centrifuged at 1,200 x g for 15 min to remove cellular debris. IL-8 protein was analyzed using a commercially available enzyme linked immunosorbant assay (ELISA) IL-8 kit (R&D, Minneapolis, MN).

Statistical Analysis
Statistical analyses were performed using Statview 4.5 (Abacus Concepts, Inc., Berkeley, CA). The concentration of IL-8 in cell supernatants was compared by ANOVA (ANOVA) and then subsequent multiple comparisons by the Scheffe-test. Comparison of IL-8 concentration in different samples was conducted via a non-paired t-test. All values were expressed as mean ± standard error of the mean.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Large Tidal Volume Ventilation Increases LMW HA Production and HAS3 mRNA Synthesis
To determine the effect of lung stretch on HA synthesis and HAS mRNA expression, rats were mechanically ventilated for 2 h with VT 20 cc/kg. Total HA was in lung tissue sections from ventilated rats was localized with bHABP and compared with lung tissue from control, nonventilated animals. With high VT ventilation, HA was deposited in the interstitium of the lung parenchyma and in airway epithelium as compared with the control lung tissue (Figure 1). Because bHABP binds both HMW and LMW HA, bHABP staining recognizes total HA accumulation. HAdase pretreatment of the lung section abolished HA staining, confirming the specificity of HA staining (Figure 1). Extent of HA staining was measured by microscopic image analysis. The HA staining in animals ventilated at VT 20 cc/kg was 336,602 arbritary units (AU) ± 55,575 compared with control nonventilated animals, which showed 142,997 AU ± 31,076, and to HAdase treated sections (negative control, no HA staining) P < 0.02. To identify the forms of HA present in ventilated rat lungs, we performed column chromatography to separate HA from the sulfated proteoglycans and extraneous proteins in the lung tissue sample. The pattern of 25 fractions that eluted with a salt gradient of 0–0.2 M NaCl containing HA (total of 100 fractions were collected) is shown in Figure 2. HA from rats ventilated at VT 20 cc/kg (Figure 2A) was eluted from the column at a wider range of conductivity of 9–15 and in multiple peaks compared with the HA from rats ventilated at 7 cc/kg (Figure 2B) and control nonventilated animals (Figure 2C) that was eluted at a narrow range of conductivity of 12–13 and in a single peak. These data showed the greater heterogeneous nature of the HA isolated from rats ventilated at VT 20 cc/kg. The amount of HA in the pooled column fractions that were freeze-dried from the rat lung was determined (Figure 3A). There was a significant increase in the amount of total HA in the rats ventilated at VT 20 cc/kg as compared with rats ventilated at 7 cc/kg and nonventilated animals.



View larger version (60K):
[in this window]
[in a new window]
 
Figure 1. Histochemical staining of HA in lungs of rats ventilated at high and low tidal volumes. Localization of HA in lung tissue section using bHABP. This technique localizes both LMW and HMW forms of HA. There was an increase in total HA in the large airways and interstitium of lung parenchyma in mechanically ventilated animals as compared with control nonventilated animals. HAdase pretreatment of lung section abolished HA staining, confirming the specificity of HA staining.

 


View larger version (22K):
[in this window]
[in a new window]
 
Figure 2. Isolation of HA from rats ventilated at high and low tidal volumes. Elution pattern for HA on the DEAE-52 anion exchange column from animals ventilated at VT 20 cc/kg (A; triangles), animals ventilated at VT 7 cc/kg (B; squares), and control nonventilated animals (C; squares). In animals ventilated at 20 cc/kg, HA eluted in a very heterogeneous pattern at conductivity levels 9–15, whereas HA from animals ventilated at 7 cc/kg and control nonventilated animals eluted in a narrow range 12–15 in a single peak. This indicates that multiple forms of HA are likely to be present in the animals ventilated at 20 cc/kg. The left-hand axis is a measure of the uronic acid content of each fraction, which corresponds to the amount of HA present. The right-hand axis is a measure of the conductivity. Closed diamonds show the conductivity of the eluent.

 


View larger version (35K):
[in this window]
[in a new window]
 
Figure 3. HA production in lungs of rats exposed to high and low tidal volume ventilation. (A) Total HA content in mg/g lung tissue from rats ventilated with VT 20 cc/kg compared with lung tissue from rats ventilated with VT 7 cc/kg, and in control, nonventilated rats. *P < 0.01 versus control. (B) Cellulose acetate plate of the total HA fraction, VT 20 cc/kg, VT 7 cc/kg and control, nonventilated rats. Note the complete disappearance of the HA band following HAdase treatment of the sample, confirming the identity of HA. GAG standards (Std); CS, chondroitin sulfate; HA, hyaluronan; DS, dermatan sulfate; HP, heparin; HAdase, hyaluronidase. Standard (Std) (lane 1); Std +HAdase (lane 2); Nonventilated control (C) (lane 3); C+HAdase (lane 4); VT 7 cc/kg (lane 5); VT 7 cc/kg+HAdase (lane 6); VT 20 cc/kg (lane 7); and VT 20 cc/kg (lane 8). (C) RT-PCR of HAS isoforms from rat lungs shows an upregulation of HAS 3 (712 bp) in lungs of animals ventilated with VT 20 cc/kg compared with VT 7 cc/kg and nonventilated animals.

 
Using cellulose acetate electrophoresis, we confirmed the identity of the major GAG molecule within the column fraction as HA by comparing its mobility to that of standard HA and HAdase treatment of the fraction. Because the HAdase treatment fraction was completely digested, as seen by the disappearance of the HA band, the GAG in the fraction from the ventilated lungs and controls was confirmed to be HA (Figure 3B).

HA standards run on agarose gel electrophoresis was used to determine the molecular weight of HA that accumulated in the animals ventilated at VT 20 cc/kg, animals ventilated at VT 7 cc/kg and control nonventilated animals. A standard graph was plotted between log molecular weight versus relative mobility (Figure 4A). The molecular weight of the HA in VT 20 cc/kg was extrapolated from a standard curve (Figure 4B). In VT 20 cc/kg rat lungs, two LMW (MWs 180 kD and 370 kD) forms and one HMW (MW 3,100 kD) form of HA accumulated compared with animals ventilated at 7 cc/kg (MW 2,730 kD) and control nonventilated animals (MW 3,100 kD) in which only the HMW form accumulated.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. Measurement of the molecular weights of the HA forms. (A) Graph of HA standards of known molecular weight compared with their relative mobility. Samples were electrophoresed on 0.5% agarose gels, which separate HA on the basis of molecular weight. This standard curve was used to estimate the molecular weight of the forms of HA found in tissue samples and in the commercially purchased HA samples. (B) Molecular weights (MW) of the HA fractions. The left side of the graph shows the MW of HA in the ventilated and nonventilated rats. The middle portion of the graph shows MW of HA from stretched human fetal (IMR-90) and adult (NHLF) fibroblast cells. The right side shows the molecular weights of the LMW and HMW forms of HA, which were commercially purchased for cell stimulation studies.

 
HAS 3 and HAS 2 mRNA expression were measured by RT-PCR on rat lung tissue from animals ventilated with VT 20 cc/kg and VT 7 cc/kg, and from nonventilated animals. Animals ventilated at VT 20 cc/kg showed an increase in HAS 3 mRNA compared with animals from the other two groups (Figure 3C). There was no increase in HAS 2 mRNA expression (data not shown). Low levels of HAS 2 and HAS 3 were observed in animals with VT 7 cc/kg and nonventilated animals.

Mechanical Stretch–Induced LMW HA Is Dependent on HAS 3 Expression in Human Fibroblasts
To explore the role of HAS 3 mRNA expression in stretch-induced LMW HA production, we isolated and analyzed HA from the supernatants of stretched human fetal fibroblasts. Cyclic stretch caused a significant and time-dependent increase in HA, which was maximal after 4-h stretch, the longest stretch period we employed (Figure 5A). Cellulose acetate chromatography confirmed the stretch-induced production of HA in vitro. HAdase treatment of the fraction caused the complete disappearance of the HA band (data not shown). The HA produced by in vitro stretched fetal fibroblasts was of LMW (178 kD); unstretched control cultures released HMW HA (> 1,600 kD, 1,600 kD) (Figure 4B). To explore the role of HAS stretch-induced LMW HA production, HAS mRNA expression was measured by RT-PCR. Stretch of fetal fibroblasts upregulated expression of HAS 3 mRNA (283 bp) (Figure 5B), but not HAS 1 and HAS 2 (data not shown) in response to 30 min of stretch; this was sustained over at least a 2-h stretch period. This expression decreased again during a 4-h stretch. Low levels of HAS 2 and 3 were expressed in nonstretched fetal fibroblasts. Cyclohexamide and dexamethasone, which have previously been shown to block IL-1ß induction of HAS 3 mRNA nonspecifically, inhibited the mechanical stretch-induced increase of HAS 3 mRNA (Figure 5B). Cyclohexamide and dexamethasone also blocked stretch-induced accumulation of HA in cultured cells stretched for 4 h (Figure 5A). These data suggest that stretch-induced accumulation of LMW HA was linked to expression of HAS 3 mRNA and therefore was, at least in part, created by de novo synthesis.



View larger version (38K):
[in this window]
[in a new window]
 
Figure 5. Effect of cyclic stretch on fetal lung fibroblasts. (A) Total HA in the fetal fibroblast culture supernatant in the presence and absence of the nonspecific inhibitors; Cyc, Dex, protein tyrosine kinases (PTK) Inh, JAK 2 Inh, and mitogen-activated protein kinase (MAPK) Inh. Cyc, Dex, PTK Inh, and JAK Inh, but not MAPK Inh, blocked accumulation of HA. *P < 0.01 versus Controls. (B) RT-PCR shows HAS3 gene expression (283 bp) at different time points of stretch with and without inhibitors. Inhibitors (Inh) were cyclohexamide (Cyc) (10 pM) and dexamethasone (Dex) (10 nM), nonspecific inhibitors of HA, genistein (a broad range PTK inh, 10 µg), AG490 (JAK 2 inh, 1 µM), and UO126 (MEK1,2 inh, 20 µM). Cyc, Dex, PTK Inh and JAK Inh and not MAPK Inh blocked upregulation of HAS 3 mRNA. (C) Immunoblot of stretch-induced activation of JAK 2 (p-Jak2) was performed on cell lysate of fibroblasts. JAK 2 (MW 130 kD) is activated within 5 min after the onset of stretch, and it remains active over at least 30 min of stretch.

 
To confirm the stretch response observed in human fetal fibroblasts, we used normal adult human fibroblasts. In those cells, cyclic stretch also caused a significant time-dependent increase in PGs, which was maximal at 4-h stretch in adult lung fibroblasts (Figure 6B). The PGs extracted from the supernatant of normal adult fibroblasts were analyzed by cellulose acetate electrophoresis. An HA-like fraction was identified based on its mobility compared with standard HA, and its disappearance following HAdase treatment, whereupon it was completely degraded and was replaced by a PG identified as CS. The HA-like band was completely digested by HAdase and Condroitin ABCase. Therefore, the major PGs upregulated by stretch in normal human adult lung fibroblasts are HA and CS (Figure 6A). We did not find CS in fetal fibroblasts. The PGs produced by in vitro stretched adult fibroblasts were identified as LMW (219 kD) forms compared with nonstretched cells, which produced HMW forms only (1,600 kD) (Figure 4B).



View larger version (38K):
[in this window]
[in a new window]
 
Figure 6. Effect of cyclic stretch on normal human adult lung fibroblasts. (A) Results of cellulose acetate electrophoresis of the total HA fractions from stretched and control nonstretched cells. The HA-like band from stretched cells eluted as HMW HA (lane 3) and LMW HA (lane 5) forms after Sepharose CL4B chromatography; that from nonstretched cell culture supernatant eluted as HMW HA (lane 1) forms from Sepharose CL-4B. Subsequent HAdase treatment of these samples resulted in the disappearance of the HA band and the appearance of a CS band (lanes 4 and 6). Chondroitin ABCase treatment of the fraction caused complete disappearance of both bands (data not shown). The uronic acid fractions in adult fibroblasts contained HA and CS. GAG standards (Std); CS, chondroitin sulfate; HA, hyaluronan; HAdase, hyaluronidase. (B) Total uronic acid in adult lung fibroblast supernatant in the presence (open bars) and absence (closed bars) of JAK 2 inhibitor, AG490. AG490 blocked accumulation of uronic acid. *P < 0.01 versus Controls. (C) RT-PCR shows the HAS gene expression at different time points during stretch. Adult fibroblasts were pretreated with AG490 (Jak2 inhibitor, Jak 2 inh, 1 µM). (D) Immunoblot of stretch-induced activation of JAK 2 (p-Jak2) was performed on fibroblast lysates. Stretch-activated JAK 2 (MW 130 kD) within 5 min after the onset of stretch and this effect was sustained throughout a 30-min stretch.

 
To confirm the role of HAS 3 in stretch-induced LMW HA-form production, we also measured the expression of HAS 3 mRNA by RT-PCR in adult lung fibroblasts (Figure 6B) as we had done in fetal fibroblasts (Figure 5B). Stretch-induced upregulation of HAS 3 at 30 min of stretch; this was sustained through the 4-h stretch. These data suggest that the transient response of fetal fibroblasts to stretch-induced injury differs from the more sustained response of adult fibroblasts.

Stretch-Induced HAS 3 mRNA Expression Is Dependent on JAK 2
To examine the role of JAK-2 as a signal transduction pathway in stretched fetal fibroblasts, we used the non-specific protein tyrosine kinase inhibitor genistein, and the specific JAK 2 inhibitor AG490. Both inhibitors blocked stretch-induced HAS 3 mRNA expression as well as accumulation of LMW HA (Figures 5A and 5B). Interestingly, the MEK 1/2 inhibitor U0126 did not block either stretch-induced HAS 3 mRNA expression or accumulation of LMW HA (Figures 5A and 5B). This suggests that stretch-induced accumulation of HA depends on the JAK 2 pathway, whereas the p42/p44 MAPK pathway is not required. To confirm that JAK2 is part of the signal transduction pathway in stretch-induced upregulation of HAS 3 and subsequent accumulation of LMW HA in fetal fibroblasts, we measured activation of JAK2 (p-JAK2/JAK 2) using Western blot analysis. Phosphorylated-JAK2 was upregulated within 5 min after the onset of stretch, and the signal was sustained over a 30-min stretch (Figure 5C).

To confirm that JAK2 is part of the signal transduction pathway in stretch-induced upregulation of HAS 3 and accumulation of LMW forms of HA in adult fibroblasts, we added AG490, a specific JAK2 inhibitor, and then measured activation of p-JAK 2 using Western blot analysis. AG490 blocked stretch-induced accumulation of LMW HA forms and upregulation of HAS 3 in the adult fibroblasts (Figures 6A and 6B), confirming the findings made with fetal fibroblasts. Here, too, p-JAK2 was upregulated as early as 5 min stretch, and the signal was sustained over at least a 30-min stretch (Figure 6C).

These results are consistent with the conclusion that stretch-induced production of LMW HA by lung fibroblasts is dependent on new HAS 3 mRNA expression regulated by Jak-2 kinase.

LMW HA Induced IL-8 Expression in Epithelial Cells and Augmented Stretch-Induced IL-8 Production
To examine the proinflammatory effects of LMW HA, we purchased commercially available forms of HA in sizes similar to those found in our in vivo and cell culture studies. These three forms of LMW HA and one form of HMW HA were closest in molecular weight to that which accumulated in intact rats ventilated at VT 20 cc/kg, and in culture medium from stretched fetal and adult fibroblasts (180–370 kD). The molecular weights of the commercially purchased HA fractions were confirmed by agarose gel electrophoresis using the same techniques we used to measure the weight of the HA fractions obtained from the rat lungs. Commercially purchased HAs were 370 kD, 600 kD, 740 kD, and 2,300 kD (Figure 4B). We also confirmed the purity of the commercially available HAs using cellulose acetate electrophoresis of samples with and without HAdase, DNase, and heat treatment. Complete disappearance of the HA band with HAdase treatment confirmed the identity of HA. DNase treatment and heat treatment did not degrade HA in the samples, confirming that the samples were not appreciably contaminated with DNA or protein. The absence of DNA in key fractions was re-confirmed using agarose gel electrophoresis and obtaining an absorption spectrum of sample between 200 and 300 nm (data not shown). Static, nonstretched A549 cells, a type II–like human alveolar epithelial cell line cells, capable of producing IL-8, were exposed to HA at 100 µg/ml for 6 h. Only the lowest molecular weight HA (370 kD) caused a significant increase in IL-8 production as compared with the HA of higher molecular weight (600–2,300 kD; Figure 7A). LMW HA and not HMW HA induced a dose-dependent increase of IL-8 in A549 cells. The optimal dose for IL-8 production was 100 µg/ml (Figure 7B).




View larger version (45K):
[in this window]
[in a new window]
 
Figure 7. LMW HA induction of IL-8 in A549 cells. (A) IL-8 concentration in supernatants of cultured A549 cells stimulated with commercially available LMW HA and HMW HA similar in molecular weight to that which accumulated in VILI. HA of MW 370 kD caused a significant increase in IL-8 production as compared with higher MW forms of 500–2,300 kD and in control cells not treated with HA. *P < 0.001 versus all other forms. (B) Dose dependence of LMW HA (370 kD) stimulation showed a maximal response at 100 µg/ml, but a dose of 50 µg/ml induced significant IL-8 compared with a dose of 10 µg/ml or untreated sample. Concentrations of 150–200 µg/ml of LMW HA caused no significant increase in IL-8 production compared with 100 µg/ml. There was no increase in IL-8 production with HMW HA (2,300 kD). *P < 0.01 versus Control. (C) IL-8 production in supernatants of A549 cell cultures stimulated with commercially available LMW HA and HA from fetal fibroblasts (LMW HA 178 kD and not HMW > 1,600 + 1,600 kD) induced significant IL-8 production in static culture and augmented stretch-induced IL-8 in A549 cells. *P < 0.01 versus Control and #P < 0.01 versus Stretch.

 
We confirmed these findings in human bronchiolar epithelial cells (BEAS-2B), another cell type in the lung capable of producing IL-8. BEAS-2B cells were exposed to HA at 100 µg/ml with 10 µg/ml Polymixin B for 6 h. Only the LMW HA (370 kD) caused a significant increase in IL-8 production (LMW: 820.857 ± 237.3) as compared with the HA of higher molecular weight (2,300 kD) (HMW: 37 ± 12.7 and Control: 3.430 ± 1.2).

IL-8 production was measured in A549 cells stimulated with HA fractions of molecular weight 370 kD (LMW HA; 272.31 ± 37.687) and 2,300 kD (HMW HA; 30.75 ± 9.5) with and without HAdase treatment (LMW HA; 5.55 ± 3.03 and HMW HA; 0.75 ± 0.5), heat treatment (LMW HA; 266.15 ± 9.5 and HMW HA; 30.5 ± 9.5) and DNase treatment (LMW HA; 280 ± 10.5 and HMW HA; 32.3 ± 0.5). Inactivation of HA with HAdase treatment confirmed that LMW HA induced IL-8 production. Neither heat nor DNase treatments altered LMW HA stimulation of IL-8 production. Therefore, it is the LMW HA in this sample that induces IL-8, and not contaminating protein or DNA. Although LPS could potentially have contaminated these samples, it was not a factor here: the endotoxin content of all the samples was < 0.03 EU/ml.

To explore the role of LMW HA in IL-8 production in cells undergoing cyclic stretch, standard HAs described above were used to stimulate A549 cells undergoing cyclic stretch. Commercially purchased LMW HAs and not HMW HA augmented stretch-induced IL-8 production (Figure 7C).

The LMW HA from the stretched fibroblasts and the HMW HA from the nonstretched fibroblasts were used to confirm the role of LMW HA in cytokine production in VILI. The purified LMW HA (178 kD) and HMW HA (> 1,600 + 1,600 kD) from fetal fibroblasts also induced IL-8 production in statically cultured A549 cells, and augmented stretch-induced IL-8 production (Figure 7C). Our results suggest that LMW HA is an additional mechanism for increased production of IL-8 observed in VILI.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study we found that high tidal volume ventilation of rat lungs caused changes in their production of HA (Figures 1 and 3), a component of the ECM. LMW HA in the size ranging from 180–370 kD accumulated in rats ventilated at VT 20 cc/kg, but not in rats ventilated at VT 7 cc/kg (Figure 4), and this LMW HA accumulation was accompanied by an increase in the expression of HAS 3 mRNA (Figures 5 and 6). We used an in vitro model of lung cell stretch to explore the mechanism of stretch-induced production of LMW HA and the potential role of LMWHA in cytokine production. We identified a potential role for the JAK 2 signal transduction pathway in stretch-induced production of the LMW HA (Figures 5 and 6) and documented an increase in the proinflammatory cytokine IL-8 following exposure of human type II–like A549 cells to this LMW HA in an in vitro model of lung cell stretch (Figure 7).

In addition to HA, other changes in ECM have been hypothesized to contribute to the pathogenesis of VILI. Berg and coworkers (5) described increased levels of procollagen and fibronectin mRNAs after ventilation with high levels of PEEP. Parker and colleagues (4) found that ventilation at high peak airway pressures also led to increased mRNA expression of these ECM components. In vitro studies by Xu and associates (2, 3) and others (6, 7) have demonstrated the direct effects of mechanical strain on ECM synthesis and secretion. Jamal and coworkers (8) have shown that in vivo mechanical strain selectively induces increased synthesis and protein expression of PGs. Thus, the ECM appears to play an important role in VILI.

Three isoforms of HA synthase have previously been identified and cloned (25). The product of HAS 3 is HA of size 200–300 kD; HAS 1 and HAS 2 make larger HA, with sizes up to 2,000 kD (26). Although each form of HAS protein can catalyze hyaluronan biosynthesis in eukaryotic cells, their enzymatic properties differ. These distinct enzymatic properties may drive distinct physiologic functions. HAS 3 is intrinsically more catalytically active than HAS 2, which in turn is intrinsically more active than HAS 1. HAS 3 has a higher Vmax than HAS 1 or HAS 2 and can produce large amounts of LMW HA in short periods of time (26). Thus in VILI, LMW HA was found in the same size range as produced in mammalian cell culture via HAS 3, suggesting that de novo synthesis of LMW HA by HAS 3 is one possible mechanism that can cause accumulation of LMW HA in the animal model of VILI.

LMW HA may also be produced by breakdown of HMW HA. In vivo, HA fragmentation has been shown to result from regulated expression of secreted hyaluronidase (27) or from oxidation by reactive oxidant species (28). Hyaluronidase (Hyal-2) generated HA fragments of 10–20 kD (29). Therefore in VILI, LMW HA may be produced by multiple processes.

To explore the role of HAS 3 in lung cell stretch we used human fetal and normal adult lung fibroblasts exposed to cyclic stretch in vitro. Both fetal and adult lung fibroblasts produced similar sizes of LMW HA in response to stretch, and this production paralleled an increase in the mRNA of the HAS 3 enzyme. Cyclohexamide and dexamethasone, which have diverse chemical structures, blocked stretch-induced upregulation of HAS 3 mRNA and stretch-induced accumulation of LMW HA. Inhibition of HAS 3 mRNA transcription by cyclohexamide suggests that de novo protein synthesis was required for induction of the HAS 3 gene. We found that one protein involved in the stretch-induced expression of HAS 3 was JAK2. The mechanism of dexamethasone inhibition of HAS 3 gene expression is unknown. These data suggested that stretch-induced production of LMW HA is in part dependent on HAS 3.

Cyclic stretch has been shown to activate signal transduction pathways including JNK, ERK1/2, p38 and tyrosine kinases. We found that a PTK inhibitor (genistein) and a JAK 2 (AG490) inhibitor, but not a MEK 1/2 inhibitor, blocked HA production. These data suggest that stretch-induced production of LMW HA is dependent on HAS 3 that may be regulated by JAK 2 kinase. Angiotensin II remodeling of the ECM has also been shown to be regulated by JAK 2 kinase. These data are consistent in supporting an important role of the JAK-STAT pathway in the regulation of the ECM composition (18).

HAS isoforms have been found to be independently expressed and activated in mammalian cells (15, 26). Both fetal and adult lung fibroblasts express HAS 2 and HAS 3. Dowthwaite and colleagues (30) also found that HAS 3 is stretch-responsive, and that HAS 3 levels are correlated with accumulation of HA in embryonic fibrocartilage cells. It has been found that interferon-{gamma}, tumor necrosis factor-{alpha}, and IL-1ß each increased transcription of HAS, an event that correlated with increased production of HA (31). However, Recklies and associates (32) demonstrated that changes in transcriptional level of HAS genes do not always correlate with changes in the secretion of HA. This suggested that the regulation of HAS by cytokines was post-transcriptionally regulated, and thus a multifaceted process involving transcriptional and post-transcriptional regulation. In our studies, expression of HAS3 directly correlated with HA production, suggesting that there was no post-transcriptional regulation.

In our in vivo model of VILI, we have previously shown the development of noncardiogenic pulmonary edema with neutrophil influx that was dependent on stretch-induced MIP-2 production (9). However, the mechanisms of stretch-induced cytokine production and inflammation have not been fully characterized and may involve many factors. Others have shown that under physiologic conditions, HA exists in excess of 1,000 kD. However, the present study shows that following tissue injury, HA fragments of lower molecular mass accumulated. The LMW HA of the size range that accumulated in our model of VILI also induced IL-8 production in a dose-dependent manner in human type II–like alveolar epithelial A549 cells. High molecular weight HA was incapable of this effect. These findings with commercially obtained HA were confirmed by LMW HA and HMW HA purified from the supernatants of fetal fibroblasts. LMW HA from stretched fibroblasts induced IL-8 in static A549 cells and augmented stretch-induced IL-8 production by these cells. These data are consistent with the hypothesis LMW HA produced in VILI can serve as an active proinflammatory stimulant in vivo, and may provide an alternative mechanism to increase cytokine production.

HA has been shown to produce distinct biological effects depending on the molecular weight and cellular source such as macrophages and endothelial cells. HA with molecular size of 250 kD but not HMW precursors induces the expression of inflammatory genes (1215). Similar results have been shown with renal tubular cells, T-24 carcinoma cells and eosinophils. In contrast, a different size requirement is observed to affect dendritic cells, where 6–20 oligosaccharides induce inflammatory gene expression. HMW HA activated protein tyrosine kinases to a limited extent in endothelial cells; this activation is enhanced several fold in the presence of small HA fragments. In 1989 West and Kumar (33) showed that oligomers of 8–16 disaccharides prepared by enzymatic digestion of native HA-induced angiogenesis in the chick corneal assay, whereas native high molecular weight polymer did not. Other authors have suggested that the observed induction of cytokines is due to impurities in the HA fragments, and not to the HA itself (34). Like Balazas and coworkers (35), we have ruled out contaminating proteins, DNA, and LPS in the proinflammatory properties of these forms of LMW HA. In contrast, we have shown that LMW HA is responsible for these effects, because inactivation of LMW HA with HAdase successfully blocked the stimulation. Thus, LMW HA, and not contaminants, are responsible for the induction of cytokines.

In adult fibroblasts we found increased expression of both HA and CS. In normal lung tissue, HA is not covalently associated with proteins, although HA does noncovalently associate with versican, the CS-containing PG in the lung. After we treated the GAGs isolated from the supernatants of the stretched adult fibroblasts with HAdase, the HA was degraded and then the CS became visible. Others have shown that stretch increased the production of versican mRNA and versican and may be the source of CS in cyclic stretch (8).

In conclusion, large VT ventilation causes production of LMW HA, which is accompanied by increased HAS 3 mRNA expression. In vitro, cyclic stretch of fibroblasts also induces production of LMW HA, which is dependent on HAS 3 activity and is regulated by the JAK 2 pathway. Stretch-induced LMW HA causes production of IL-8 in type II–like cells. LMW HA production may play an important role in VILI. Elucidation of the molecular mechanism of accumulation of HA and HA-induced cytokine production may lead to the development of new strategies to interrupt the exuberant inflammatory response characteristic of ARDS and VILI.


    Acknowledgments
 
The authors thank Dr. Charles Underhill, Department of Oncology, EG19A NRB, Washington, DC, for the generous gift of bHABP. R.M.D. is a recipient of American Heart Association Scientist Development Grant and American Lung Association Grant. D.A.Q. is supported by NIH #HL03920–01. M.M.M. is supported by NIH #5T32 HL07874–05. C.A.H. is supported by NIH #HL39150–13 and Shriners Hospital for Burns #8620. The authors thank Susannah W. Wood for her generous support of this work and Kathie Sweeney Laing for her assistance in preparation of the manuscript.

Received in original form August 23, 2002

Received in final form April 23, 2003


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Dreyfuss, D., and G. Saumon. 1998. Ventilator-induced lung injury: lessons from experimental studies. Am. J. Respir. Crit. Care Med. 157:294–323.
  2. Xu, J., M. Liu, I. Canniggia, and M. Post. 1996. Mechanical strain induces constitutive and regulated secretion of glycosaminoglycans and proteoglycans in fetal lung cells. J. Cell Sci. 109:1605–1613.[Abstract]
  3. Xu, J., M. Liu, and M. Post. 1999. Differential regulation of extracellular matrix molecules by mechanical strain of fetal lung cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 276:L728–L735.[Abstract/Free Full Text]
  4. Parker, J. C., E. C. Breen, and J. B. West. 1997. High vascular and airway pressures increase interstitial protein mRNA expression in isolated rat lungs. J. Appl. Physiol. 83:1697–1705.[Abstract/Free Full Text]
  5. Berg, J. T., Z. Fu, E. C. Breen, H. C. Tran, O. Mathieu-Costello, and J. West. 1997. High lung inflation increases mRNA levels of ECM components and growth factors in lung parenchyma. J. Appl. Physiol. 83:120–128.[Abstract/Free Full Text]
  6. Breen, E. C. 2000. Mechanical strain increases type I collagen expression in pulmonary fibroblasts in vitro. J. Appl. Physiol. 88:203–209.[Abstract/Free Full Text]
  7. Mourgeon, E., J. Xu, A. Transwell, M. Liu, and M. Post. 1999. Mechanical strain-induced posttranscriptional regulation of fibronectin production in fetal lung cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 277:L142–L149.[Abstract/Free Full Text]
  8. Al-Jamal, R., and M. S. Ludwig. 2001. Changes in proteoglycans and lung tissue mechanics during excessive mechanical ventilation in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1078–L1087.[Abstract/Free Full Text]
  9. Quinn, D. A., R. K. Moufarrej, A. Volokhav, and C. A. Hales. 2002. The interactions of lung stretch, hyperoxia, and MIP-2 production in ventilator-induced lung injury. J. Appl. Physiol. Aug;93:517–525.
  10. Quinn, D. A., A. M. Tager, P. Joseph, J. Bonventre, T. Force, and C. A. Hales. 1999. Stretch-induced mitogen-activated protein kinase activation and IL-8 production in type-2 alveolar cells. Chest 116:89S–90S.[Free Full Text]
  11. Hallgren, R., T. Samuelsson, T. C. Laurent, and J. Modig. 1989. Accumulation of HA in lung in ARDS. Am. Rev. Respir. Dis. 139:682–687.[Medline]
  12. McKee, C., M. Penno, and M. K. Cowman. 1996. Hyaluronan fragments induce chemokine gene expression in alveolar macrophages: The role of HA size and CD44. J. Clin. Invest. 98:2403–2413.[Medline]
  13. Horton, M. R., C. M. McKee, C. Bao, F. Liao, J. M. Farber, R. J. Hofge-DuFou, E. Pure, B. L. Oliver, T. M. Wright, and P. W. Noble. 1998. HA fragments synergize with interferon-gamma to induce C–X-C chemokines mig and interferon-inducible protein-10 mouse macrophages. J. Biol. Chem. 273:35088–35094.[Abstract/Free Full Text]
  14. Noble, P. W., C. M. McKee, M. K. Cowman, and H. S. Shin. 1996. Hyaluronate fragments activate an NF-kappa B/Ikappa B alpha autoregulatory loop in murine macrophages. J. Exp. Med. 183:2373–2378.[Abstract/Free Full Text]
  15. Itano, N., T. Sawa, P. Lenas, Y. Yamada, M. Imagawa, T. Shinomura, M. Hamaguch, Y. Yoshida, Y. Ohnuki, S. Miyauchi, A. P. Spicer, J. A. McDonald, and K. Kimata. 1999. Three forms of mammalian HA synthase have distinct enzymatic properties. J. Biol. Chem. 274:25085–25092.[Abstract/Free Full Text]
  16. Liu, M., K. Transwell, and M. Post. 1999. Mechanical force-induced signal transduction in lung cells. Am. J. Physiol. 277:L667–L683.
  17. Pan, J., K. Fukuda, M. Saito, J. Matsuzaki, H. Kodama, M. Sano, T. Takahashi, T. Kato, and S. Ogawa. 1999. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ. Res. 84:1127–1136.[Abstract/Free Full Text]
  18. Watson, S., T. Burnside, and W. Carver. 1998. Angiotensin II-stimulated collagen gel contraction by heart fibroblasts: role of the AT1 receptor and tyrosine kinase. J. Cell. Physiol. 177:224–231.[CrossRef][Medline]
  19. Hales, C. A., H. K. Du, A. Volokhov, R. Mourfarrej, and D. A. Quinn. 2001. Aquaporin channels may modulate ventilator-induced lung injury. Respir. Physiol. 124:159–166.[CrossRef][Medline]
  20. Cheng, G. C., W. H. Briggs, D. S. Gerson, P. Libby, A. J. Grodzinsky, M. I. Gray, and R. T. Lee. 1997. Mechanical strain tightly controls fibroblast growth factor from cultured human vascular smooth muscle cells. Circ. Res. 80:28–36.[Abstract/Free Full Text]
  21. Schaffer, J. L., M. Rizen, G. J. L'Italien, A. Benbrahim, J. Megerman, L. C. Gerstenfeld, and M. I. Gray. 1994. Devise for application of dynamic biaxially uniform and isotropic strain to flexible cell culture membrane. J. Orthop. Res. 12:709–719.[CrossRef][Medline]
  22. Bitter, T., and H. M. Muir. 1962. A modified uronic acid carbazole reaction. Anal. Biochem. 4:330–334.[CrossRef][Medline]
  23. Cappelletti, R., M. Del Rosso, and V. P. Chiarugi. 1979. A new electrophoretic method for complete separation off all known glycosaminglycans in a monodimensional run. Anal. Biochem. 99:311–315.[CrossRef][Medline]
  24. Lee, H. G., and M. K. Cowman. 1994. An agarose gel electrophoresis method for analysis of HA molecular weight distribution. Anal. Biochem. 219:278–287.[CrossRef][Medline]
  25. Weigel, P. H., V. C. Hascall, and M. Tammi. 1997. Hyaluronan synthase. J. Biol. Chem. 272:13997–14000.[Free Full Text]
  26. Spicer, A. P., J. S. Olson, and J. A. McDonald. 1997. Molecular cloning and characterization of cDNA encoding the third putative mammalian HAS. J. Biol. Chem. 272:8957–8961.[Abstract/Free Full Text]
  27. Csoka, T. B., G. I. Frost, and R. Stern. 1997. Hyaluronidase in tissue invasion. Invasion Metastasis 17:297–311.[Medline]
  28. Uchiyama, H., Y. Dobashi, K. Ohkuchi, and K. Nagasawa. 1990. Chemical change involved in oxidative reductive depolymerization of hyaluronic acid. J. Biol. Chem. 265:7753–7759.[Abstract/Free Full Text]
  29. Lepperdinger, G., B. Strobl, and G. Kreil. 1998. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem. 273:22466–22470.[Abstract/Free Full Text]
  30. Dowthwaite, G. P., A. C. Ward, J. Flannely, R. F. L. Suswillo, C. R. Flannery, C. W. Archer, and W. Pitsillides. 1999. The effect of mechanical ventilation on hyaluronan metabolism in embryonic fibrocartilage cells. Matrix Biol. 18:523–531.[CrossRef][Medline]
  31. Ijuin, C., S. Ohno, K. Tanimoto, K. Honda, and K. Tanne. 2001. Regulation of hyaluronan synthase gene expression in human peridontal ligament cells by tumor necrosis factor-alpha, interleukin-1beta and interferon-gamma. Arch. Oral Biol. 46:767–772.[CrossRef][Medline]
  32. Recklies, A. D., C. White, L. Melching, and P. J. Roughley. 2001. Differential regulation and expression of hyaluronan synthase in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem. J. 354:17–24.[CrossRef][Medline]
  33. West, D. C., I. V. Hampson, F. Arnold, and S. Kumar. 1985. Angiogenesis induced by degradation products of HA. Science 228:1324–1326.[Abstract/Free Full Text]
  34. Filion, M. C., and N. C. Phillips. 2001. Pro-inflammatory activity of contaminating DNA in hyaluronan preparations. J. Pharm. Pharmacol. 53:555–561.[CrossRef][Medline]
  35. Balazas, E. A. 1977. Ultrapure hyaluronic acid and the use thereof. United States Application No. 844:833. US patent 4, 141, 973. February 27, 1977.



This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. E. Monzon, D. Manzanares, N. Schmid, S. M. Casalino-Matsuda, and R. M. Forteza
Hyaluronidase Expression and Activity Is Regulated by Pro-Inflammatory Cytokines in Human Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. D. Ochoa, H. Baker, S. Hasak, R. Matyal, A. Salam, C. A. Hales, W. Hancock, and D. A. Quinn
Cyclic Stretch Affects Pulmonary Endothelial Cell Control of Pulmonary Smooth Muscle Cell Growth
Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 105 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. R. Ingram, A. K. T. Wann, C. K. Angel, P. J. Coleman, and J. R. Levick
Cyclic movement stimulates hyaluronan secretion into the synovial cavity of rabbit joints
J. Physiol., March 15, 2008; 586(6): 1715 - 1729.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
A. Braun, P. C. Stenger, H. E. Warriner, J. A. Zasadzinski, K. W. Lu, and H. W. Taeusch
A Freeze-Fracture Transmission Electron Microscopy and Small Angle X-Ray Diffraction Study of the Effects of Albumin, Serum, and Polymers on Clinical Lung Surfactant Microstructure
Biophys. J., July 1, 2007; 93(1): 123 - 139.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Boodoo, E. W. Spannhake, J. D. Powell, and M. R. Horton
Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L479 - L486.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Scheibner, M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton
Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2
J. Immunol., July 15, 2006; 177(2): 1272 - 1281.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Takemura, H. Itoh, N. Sagawa, S. Yura, D. Korita, K. Kakui, M. Kawamura, N. Hirota, H. Maeda, and S. Fujii
Cyclic mechanical stretch augments hyaluronan production in cultured human uterine cervical fibroblast cells
Mol. Hum. Reprod., September 1, 2005; 11(9): 659 - 665.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K.-J. Bai, A. P. Spicer, M. M. Mascarenhas, L. Yu, C. D. Ochoa, H. G. Garg, and D. A. Quinn
The Role of Hyaluronan Synthase 3 in Ventilator-induced Lung Injury
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 92 - 98.
[Abstract] [Full Text] [PDF]


This Article